Search Trudeau Institute




Trudeau scientists are determining why the lungs of humans with autoimmune disease sometimes fill with persistent clusters of T cells (red) and B cells (blue).
Research - Technology Transfer - Intellectual Property
Intellectual Property

Patents protect scientific discoveries and are an essential link between basic research and new therapeutics.

Currently Available Licensing Opportunities:

1) Use of an IL-12 receptor splice variant and molecular assay to quantify expression thereof (US patent 8,394,593)

2) SM38 Nucleic Acid Molecules (US patent 7,695,933)

3) Use of an IL-12 receptor-beta 1 splice variant to diagnose active tuberculosis (US patent 8,877,212)

To learn more the technologies listed above, please click the associated links or contact:

Atsuo Kuki, Ph.D.
President & Director
akuki@trudeauinstitute.org
1-800-638-6064





Home | Contact Us | Site Map
Trudeau Institute
154 Algonquin Avenue
Saranac Lake, NY 12983
(518) 891-3080